The present invention relates generally to receptor-selective variants of the low-density lipoprotein receptor-associated protein (RAP) and compositions thereof, methods of generating such variants and methods of using such receptor-selective RAP variant compositions for therapeutic purposes.

 
Web www.patentalert.com

< siRNA targeting Transducin (beta)-like 3 (TBL3)

> Genes Associated with Macular Degeneration

> LOW FLUSH NIACIN FORMULATION

~ 00558